• Home
  • About
  • Drug Development Pipeline
  • News
  • Investors
  • Careers
  • Contact
  • TSX.V: RKV
  • FSE: 7JO0
  • OTCMKTS: RKVTF

Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement

by Rakovina Therapeutics | Aug 12, 2026 | Uncategorized

Expanded financing broadens Rakovina’s strategic investor base and reinforces confidence in its AI-powered oncology platform DOWNLOAD VANCOUVER, British Columbia, August 12, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a...

Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement

by Rakovina Therapeutics | Aug 12, 2026 | Uncategorized

Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement DOWNLOAD VANCOUVER, British Columbia, August 12, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company...

Rakovina Therapeutics Announces $1.5 Million Private Placement

by Rakovina Therapeutics | Jul 16, 2026 | Uncategorized

DOWNLOAD VANCOUVER, British Columbia, July 15, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV)( FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, today...

Rakovina Therapeutics Announces $1.5 Million Private Placement

by Rakovina Therapeutics | Jul 15, 2026 | Uncategorized

DOWNLOAD VANCOUVER, British Columbia, July 15, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV)( FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, today announces a...

Rakovina Therapeutics Announces Q1 2026 Financial Results and Provides Corporate Update

by Rakovina Therapeutics | Jun 3, 2026 | Uncategorized

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, June 1, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through...

Rakovina Therapeutics Announces Q1 2026 Financial Results and Provides Corporate Update

by Rakovina Therapeutics | Jun 1, 2026 | Uncategorized

DOWNLOAD All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, June 1, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies...
« Older Entries
Next Entries »

Suite 720, 999 West Broadway, Vancouver, British Columbia
Canada V5Z 1K5

Home

About

Drug Development Pipeline

News

Investors

Careers

Contact

Company Disclosure

Privacy Policy

Subscribe

To Receive Company Updates

Copyright ©2020-2026 Rakovina Therapeutics Inc. All rights reserved.  | Privacy Policy | Terms of Use |  Site by Vanooms Media